字里行间 发表于 2025-3-21 18:28:41

书目名称Hyperfine Interactions (C)影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0430628<br><br>        <br><br>书目名称Hyperfine Interactions (C)读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0430628<br><br>        <br><br>

表主动 发表于 2025-3-21 22:48:17

S. V. Karyaginding to standard doses (Wilt et al. 2004). In contrast, standard treatment for cancer must become tailored to the molecular phenotype of an individual tumor, with each patient receiving a different combination of therapeutics aimed at the specific aberrant proteins driving the cancer. Tracking the a

讨厌 发表于 2025-3-22 02:30:54

http://reply.papertrans.cn/44/4307/430628/430628_3.png

BIPED 发表于 2025-3-22 04:48:03

http://reply.papertrans.cn/44/4307/430628/430628_4.png

催眠药 发表于 2025-3-22 12:12:03

http://reply.papertrans.cn/44/4307/430628/430628_5.png

Abominate 发表于 2025-3-22 16:23:26

Yu. V. Shvyd’ko,E. Gerdau,M. Lerche,M. Lucht,H. -C. Wille,E. E. Alp,P. Beckerding to standard doses (Wilt et al. 2004). In contrast, standard treatment for cancer must become tailored to the molecular phenotype of an individual tumor, with each patient receiving a different combination of therapeutics aimed at the specific aberrant proteins driving the cancer. Tracking the a

patriot 发表于 2025-3-22 17:12:25

http://reply.papertrans.cn/44/4307/430628/430628_7.png

季雨 发表于 2025-3-22 21:31:39

http://reply.papertrans.cn/44/4307/430628/430628_8.png

libertine 发表于 2025-3-23 02:23:56

http://reply.papertrans.cn/44/4307/430628/430628_9.png

blister 发表于 2025-3-23 08:19:53

http://reply.papertrans.cn/44/4307/430628/430628_10.png
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Hyperfine Interactions (C); Proceedings of the I Michael F. Thomas,John M. Williams,Terence C. Gibb Conference proceedings 2002 Springer Sc